BioNTech has received a consensus rating of Hold. The company’s average rating score is 2.38, and is based on 5...
why is biontech stock falling
Pfizer CEO Albert Bourla talks. Pfizer shares dropped sharply after the company’s 2022 sales guidance appeared to fall short of...
The US government has provided Moderna with nearly $10 billion in taxpayer money for both research and development and for...
BioNTech SE (NASDAQ:BNTX) The 14 analysts offering 12-month price forecasts for BioNTech SE have a median target of 246.86, with...
